Apogee Therapeutic

Forecast & Rating15 analysts currently cover Apogee Therapeutic, with about 20.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $130.53, about 2.8% downside from the current price of $134.28. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 47.3% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Apogee Therapeutic's outlook. Data as of Jul 25, 2026; for reference only and not investment advice.